运动诱导的神经保护对帕金森病的分子机制
Youngil Lee1, Beomsoo Ju1, Yohan Cheon1
1Molecular and Cellular Exercise Physiology Laboratory, Department of Movement Sciences and Health, Usha Kundu, MD College of Health, University of West Florida, Pensacola, FL, 32514, USA.
Sports medicine and health science
|February 6, 2026
概括
运动训练通过改善运动和认知功能为帕金森病 (PD) 患者提供神经保护. 了解练习练习的理解
科学领域:
- 神经科学和神经退行性疾病
- 运动生理学和治疗学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,影响全球数百万人,其特点是多巴胺神经元损失和运动/认知缺陷.
- 目前PD的治疗方法提供症状缓解,但不能阻止疾病的进展,强调需要疾病修改策略.
- 运动是一种有前途的非药物干预措施,有望改善PD相关障碍.
研究的目的:
- 审查帕金森病的发病和病理生理学.
- 检查临床证据,支持PD中各种运动方式和强度的神经保护益处.
- 阐明在PD中运动诱导的神经保护的分子机制.
主要方法:
- 关于帕金森病运动干预的临床研究的综合文献综述.
- 在PD模型和患者中分析研究运动调节的分子通路的研究.
- 综合关于运动对神经变因子,氧化应激,线粒体功能,ER应激和PD的自作用的证据.
主要成果:
- 临床证据表明,各种运动类型和强度可以显著改善PD患者的心理,认知和运动功能.
- 运动调节了参与PD病变的关键分子通路,包括增强神经营养支持和改善细胞应激反应.
- 特定的运动方案显示了神经保护的潜力,通过减轻氧化应激,线粒体功能障碍,内分泌网膜应激和促进自.
结论:
- 运动训练代表了一种有效的治疗策略,用于控制帕金森病的症状,并可能减缓疾病的进展.
- 了解运动效益的分子基础对于开发针对性,以运动为基础的PD疗法至关重要.
- 对最佳运动方式和强度的进一步研究可以提高帕金森病患者的生活质量.
相关概念视频
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34